Detailed information for compound 89906

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 186.253 | Formula: C12H14N2
  • H donors: 1 H acceptors: 0 LogP: 1.78 Rotable bonds: 0
    Rule of 5 violations (Lipinski): 1
  • SMILES: NC1=Nc2ccccc2[C@@H]2[C@H]1CCC2
  • InChi: 1S/C12H14N2/c13-12-10-6-3-5-8(10)9-4-1-2-7-11(9)14-12/h1-2,4,7-8,10H,3,5-6H2,(H2,13,14)/t8-,10-/m1/s1
  • InChiKey: DMSOWJWPMAVFDY-PSASIEDQSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens nitric oxide synthase 1 (neuronal) Starlite/ChEMBL References
Homo sapiens nitric oxide synthase 3 (endothelial cell) Starlite/ChEMBL References
Homo sapiens nitric oxide synthase 2, inducible Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0011 0.041 0.041
Loa Loa (eye worm) FAD binding domain-containing protein 0.0056 0.5812 0.5684
Echinococcus granulosus NADH cytochrome b5 reductase 3 0.001 0.0297 0.0297
Plasmodium falciparum S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative 0.0035 0.324 0.3033
Loa Loa (eye worm) hypothetical protein 0.0091 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0045 0.4485 1
Trypanosoma brucei NADPH-cytochrome p450 reductase, putative 0.0091 1 1
Trypanosoma cruzi p450 reductase, putative 0.0091 1 1
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0011 0.041 0.041
Echinococcus granulosus methionine synthase reductase 0.0056 0.5812 0.5812
Echinococcus granulosus ATP binding cassette subfamily B MDR:TAP 0.0011 0.041 0.041
Echinococcus multilocularis NADH cytochrome b5 reductase 3 0.001 0.0297 0.0297
Echinococcus granulosus cytochrome b5 reductase 4 0.001 0.0297 0.0297
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0011 0.041 0.041
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0011 0.041 0.041
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0011 0.041 0.041
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0011 0.041 0.041
Plasmodium vivax NADPH-cytochrome p450 reductase, putative 0.0091 1 1
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0035 0.324 0.324
Trichomonas vaginalis ABC transporter, putative 0.0011 0.041 0.041
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0091 1 1
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0011 0.041 0.041
Trypanosoma cruzi Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative 0.0035 0.324 0.3033
Leishmania major p-glycoprotein 0.0011 0.041 0.0116
Schistosoma mansoni multidrug resistance protein 0.0011 0.041 0.0116
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0011 0.041 0.041
Echinococcus granulosus ATP binding cassette subfamily B MDR:TAP 0.0011 0.041 0.041
Echinococcus granulosus NADPH cytochrome P450 reductase 0.0091 1 1
Brugia malayi FAD binding domain containing protein 0.0056 0.5812 0.5684
Giardia lamblia Hypothetical protein 0.0081 0.8755 1
Plasmodium vivax flavodoxin domain containing protein 0.0081 0.8755 0.8717
Echinococcus multilocularis NADPH dependent diflavin oxidoreductase 1 0.0091 1 1
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0011 0.041 0.041
Loa Loa (eye worm) hypothetical protein 0.0011 0.041 0.0116
Brugia malayi flavodoxin family protein 0.0035 0.324 0.3033
Trypanosoma cruzi Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative 0.0035 0.324 0.3033
Leishmania major p450 reductase, putative 0.0091 1 1
Echinococcus granulosus 5'partial|ATP binding cassette sub family B 0.0011 0.0395 0.0395
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0011 0.041 0.041
Plasmodium vivax multidrug resistance protein 1, putative 0.0011 0.041 0.0116
Chlamydia trachomatis sulfite reductase 0.0056 0.5812 1
Leishmania major NADPH-cytochrome p450 reductase-like protein 0.0091 1 1
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0011 0.041 0.041
Trichomonas vaginalis taga, putative 0.0011 0.041 0.041
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0035 0.324 0.324
Schistosoma mansoni 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase 0.0056 0.5812 0.5684
Trichomonas vaginalis ABC transporter, putative 0.0011 0.041 0.041
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0011 0.041 0.041
Entamoeba histolytica type A flavoprotein, putative 0.0035 0.324 1
Trichomonas vaginalis ABC transporter, half transporter, putative 0.0011 0.041 0.041
Echinococcus multilocularis NADPH cytochrome P450 reductase 0.0091 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0045 0.4485 1
Trichomonas vaginalis sulfite reductase, putative 0.0091 1 1
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0011 0.041 0.041
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0011 0.041 0.041
Brugia malayi ABC transporter family protein 0.0011 0.041 0.0116
Trichomonas vaginalis NADPH fad oxidoreductase, putative 0.0081 0.8755 0.8755
Echinococcus granulosus multidrug resistance protein 1 0.0011 0.041 0.041
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0011 0.041 0.041
Schistosoma mansoni NADPH flavin oxidoreductase 0.0046 0.4568 0.4402
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0011 0.041 0.041
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0011 0.041 0.041
Trichomonas vaginalis ABC transporter, putative 0.0011 0.041 0.041
Trichomonas vaginalis ABC transporter, putative 0.0011 0.041 0.041
Loa Loa (eye worm) hypothetical protein 0.0011 0.041 0.0116
Loa Loa (eye worm) ATP-binding cassette sub-family B member 2 0.0011 0.041 0.0116
Leishmania major cytochrome P450 reductase, putative 0.0081 0.8755 0.8717
Giardia lamblia Nitric oxide synthase, inducible 0.0081 0.8755 1
Trichomonas vaginalis abcb9, putative 0.0011 0.041 0.041
Treponema pallidum flavodoxin 0.0035 0.324 1
Trypanosoma brucei S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative 0.0035 0.324 0.3033
Echinococcus granulosus NADPH dependent diflavin oxidoreductase 1 0.0091 1 1
Trichomonas vaginalis abcb9, putative 0.0011 0.041 0.041
Echinococcus multilocularis multidrug resistance protein 1 0.0011 0.041 0.041
Plasmodium falciparum nitric oxide synthase, putative 0.0091 1 1
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0011 0.041 0.041
Schistosoma mansoni cytochrome P450 reductase 0.0091 1 1
Echinococcus multilocularis multidrug resistance protein 1 0.0011 0.041 0.041
Echinococcus multilocularis ATP binding cassette subfamily B (MDR:TAP) 0.0011 0.041 0.041
Entamoeba histolytica type A flavoprotein, putative 0.0035 0.324 1
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0011 0.041 0.041
Brugia malayi FAD binding domain containing protein 0.0091 1 1
Trypanosoma brucei NADPH-dependent diflavin oxidoreductase 1 0.0091 1 1
Plasmodium falciparum NADPH--cytochrome P450 reductase, putative 0.0035 0.324 0.3033
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0035 0.324 0.324
Echinococcus granulosus multidrug resistance protein 1 0.0011 0.041 0.041
Echinococcus multilocularis ATP binding cassette sub family B 0.0011 0.0395 0.0395
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0091 1 1
Toxoplasma gondii ATP-binding cassette transporter ABC.B1 0.0011 0.041 0.0269
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0091 1 1
Trichomonas vaginalis multidrug resistance protein 1, 2, putative 0.0011 0.041 0.041
Entamoeba histolytica type A flavoprotein, putative 0.0035 0.324 1
Echinococcus granulosus ATP binding cassette subfamily B MDR:TAP 0.0011 0.041 0.041
Loa Loa (eye worm) hypothetical protein 0.0011 0.0395 0.0101
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0091 1 1
Plasmodium falciparum multidrug resistance protein 1 0.0011 0.041 0.0116
Onchocerca volvulus 0.0011 0.041 1
Echinococcus granulosus ATP binding cassette subfamily B MDR:TAP 0.0011 0.041 0.041
Leishmania major ATP-binding cassette protein subfamily B, member 2, putative 0.0011 0.041 0.0116
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0011 0.041 0.041
Mycobacterium tuberculosis Probable transmembrane multidrug efflux pump 0.0011 0.041 1
Trichomonas vaginalis lipid A export ATP-binding/permease protein msba, putative 0.0011 0.041 0.041
Schistosoma mansoni multidrug resistance protein 0.0011 0.041 0.0116
Schistosoma mansoni diflavin oxidoreductase 0.0045 0.4485 0.4316
Echinococcus granulosus cytochrome b5 reductase 4 0.001 0.0297 0.0297
Entamoeba histolytica type A flavoprotein, putative 0.0035 0.324 1
Chlamydia trachomatis ABC transporter ATP binding protein/permease 0.0011 0.041 0.0204
Plasmodium vivax hypothetical protein, conserved 0.0035 0.324 0.3033
Trypanosoma cruzi NADPH--cytochrome P450 reductase, putative 0.0035 0.324 0.3033
Brugia malayi multidrug resistance protein 3 0.0011 0.041 0.0116
Trichomonas vaginalis ABC transporter, half transporter, putative 0.0011 0.041 0.041
Schistosoma mansoni smdr2 0.0011 0.041 0.0116
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0011 0.041 0.041
Trichomonas vaginalis NADPH cytochrome P450, putative 0.0035 0.324 0.324
Trichomonas vaginalis abcb9, putative 0.0011 0.041 0.041
Loa Loa (eye worm) multidrug resistance protein 3 0.0011 0.041 0.0116
Toxoplasma gondii ABC transporter transmembrane region domain-containing protein 0.0011 0.041 0.0269
Loa Loa (eye worm) flavodoxin family protein 0.0035 0.324 0.3033
Trichomonas vaginalis ATP-binding cassette transporter, putative 0.0011 0.041 0.041
Entamoeba histolytica type A flavoprotein, putative 0.0035 0.324 1
Trypanosoma cruzi NADPH-dependent FMN/FAD containing oxidoreductase, putative 0.0091 1 1
Mycobacterium ulcerans formate dehydrogenase H FdhF 0.0091 1 1
Echinococcus granulosus multidrug resistance protein 1 0.0011 0.041 0.041
Leishmania major hypothetical protein, conserved 0.0035 0.324 0.3033
Loa Loa (eye worm) FAD binding domain-containing protein 0.0091 1 1
Schistosoma mansoni multidrug resistance protein 0.0011 0.041 0.0116
Echinococcus multilocularis methionine synthase reductase 0.0056 0.5812 0.5812
Echinococcus multilocularis cytochrome b5 reductase 4 0.001 0.0297 0.0297

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.16 uM Inhibition of human neuronal nitric oxide synthase ChEMBL. 14741281
IC50 (binding) = 0.16 uM Inhibitory concentration of the compound against recombinant human (neuronal nitric oxide synthase) n-NOS ChEMBL. 12781178
IC50 (binding) = 0.16 uM Concentration required to inhibit neuronal nitric oxide synthase ChEMBL. 12182860
IC50 (binding) = 0.16 uM Inhibition of human neuronal nitric oxide synthase ChEMBL. 14741281
IC50 (binding) = 0.16 uM Inhibitory concentration of the compound against recombinant human (neuronal nitric oxide synthase) n-NOS ChEMBL. 12781178
IC50 (binding) = 0.16 uM Concentration required to inhibit neuronal nitric oxide synthase ChEMBL. 12182860
IC50 (binding) = 2.7 uM Inhibition of human inducible nitric oxide synthase ChEMBL. 14741281
IC50 (binding) = 2.7 uM Inhibitory concentration against human Inducible nitric oxide synthase ChEMBL. 12781178
IC50 (binding) = 2.7 uM In vitro inhibition of inducible nitric oxide synthase. ChEMBL. 12182860
IC50 (binding) = 2.7 uM Inhibition of human inducible nitric oxide synthase ChEMBL. 14741281
IC50 (binding) = 2.7 uM Inhibitory concentration against human Inducible nitric oxide synthase ChEMBL. 12781178
IC50 (binding) = 2.7 uM In vitro inhibition of inducible nitric oxide synthase. ChEMBL. 12182860
IC50 (binding) = 3.3 uM Inhibition of human endothelial nitric oxide synthase ChEMBL. 14741281
IC50 (binding) = 3.3 uM Inhibitory concentration against recombinant human Endothelial nitric oxide synthase ChEMBL. 12781178
IC50 (binding) = 3.3 uM In vitro inhibition of endothelial nitric oxide synthase. ChEMBL. 12182860
IC50 (binding) = 3.3 uM Inhibition of human endothelial nitric oxide synthase ChEMBL. 14741281
IC50 (binding) = 3.3 uM Inhibitory concentration against recombinant human Endothelial nitric oxide synthase ChEMBL. 12781178
IC50 (binding) = 3.3 uM In vitro inhibition of endothelial nitric oxide synthase. ChEMBL. 12182860
pKa = 9.7 pKa value of the compound was determined by photometric titration ChEMBL. 14741281
Ratio (binding) = 17 In vitro ratio of iNOS to nNOS inhibition. ChEMBL. 12182860
Ratio (binding) = 21 In vitro ratio of eNOS to nNOS inhibition. ChEMBL. 12182860
Selectivity (binding) = 17 Selectivity ratio of IC50 for i-NOS and n-NOS binding ChEMBL. 14741281
Selectivity (binding) = 17 Selectivity ratio as IC50(i-NOS)/IC50 (n-NOS) ChEMBL. 12781178
Selectivity (binding) = 21 Selectivity ratio of IC50 for e-NOS and n-NOS binding ChEMBL. 14741281
Selectivity (binding) = 21 Selectivity as ratio of IC50(e-NOS)/IC50(n-NOS) ChEMBL. 12781178

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

3 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.